Sort
166,118 grants matching “stem cells”
Regenerative Scaffold Technologies for CNS and Diabetes
$1,530,706Samuel I Stupp · Northwestern University At Chicago · R01 · FY2007 · EB
SNRP AT HUNTER COLLEGE
$1,530,593Hunter College · U54 · FY2004 · NS
GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS
$1,530,515Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2002 · HL
Molecular organization of pathways governing cell-shape formation
$1,530,433Naoko Mizuno · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
ETIB Clinical Trials
$1,530,081Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Mechanisms Of Genome Instability
$1,530,020Michael A Resnick · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Sickle cell disease molecular pathogenesis and drug therapy
$1,529,819William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Developing 3D patient-specific iPS cell derived RPE/choroid models
$1,529,649Kapil Bharti · National Eye Institute · ZIA · FY2021 · EY
NHGRI/DIR Technology Transfer Program
$1,529,565Claire Driscoll · National Human Genome Research Institute · ZIK · FY2022 · HG
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,529,275Xianyu S Hou · Basic Sciences · Z01 · FY2007 · CA
Project 2
$1,529,213Alan D Frankel · University Of California, San Francisco · U54 · FY2023 · AI
The Molecular Basis of Cell Function
$1,528,904Matthew D. Welch · University Of California Berkeley · T32 · FY2015 · GM
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$1,528,851Ira Pastan · Basic Sciences · Z01 · FY2007 · CA
UC Denver Diabetes Research Center
$1,528,762Lori Sussel · University Of Colorado Denver · P30 · FY2020 · DK
Mechanisms Of Action Of Psychoactive Drugs
$1,528,755De-Maw Chuang · National Institute Of Mental Health · ZIA · FY2010 · MH
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$1,528,567Kathleen E. Rodgers · University Of Arizona · U01 · FY2023 · AG
Primary Immune Deficiency Treatment Consortium
$1,528,517Morton Cowan · University Of California, San Francisco · U54 · FY2016 · AI
Human genetics of TB resistance in HIV-infected persons
$1,528,106Erwin Schurr · Mcgill University Health Ctr Res Inst · R01 · FY2016 · AI
The study of stem cell and neuro-vascular development
$1,528,090Yosuke Mukoyama · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
$1,528,057Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2024 · NS
MESENCHYMAL STEM CELL EXTRACELLULAR VESICLES IN THE TREATMENT OF BURN WOUNDS AND MITIGATION OF CONVERSION
$1,528,033Aegle Therapeutics Corp · · FY2020 · Defense Health Agency
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology
$1,527,851Lyle L Moldawer · University Of Florida · RM1 · FY2021 · GM
Pharmaco Response Signatures and Disease Mechanism
$1,527,753Timothy J Mitchison · Harvard Medical School · U54 · FY2010 · HG
Translating Molecular Signal Pathways to Orthopaedic Trauma Care
$1,527,646Edward M Schwarz · University Of Rochester · P50 · FY2015 · AR
Translating Molecular Signal Pathways to Orthopaedic Trauma Care
$1,527,646Edward M Schwarz · University Of Rochester · P50 · FY2016 · AR